underwent in situ aortic reconstructions (48% abdominal aortic, 52% aortoiliac) using CAAs for infective aortic aneurysm (n ¼ 25 [66%]) and aortic prosthesis infection (n ¼ 13 [34%]). Among them, four (10.5%) patients presented with aortoenteric fistula. There were four (10.5%) early (<30 days) and seven (18%) late postoperative deaths during the follow-up period (median, 13.6 months; range, 1-72 months). Early mortality was attributed to CAA rupture, whereas late mortality was not related to an aorta-related cause. Four (10.5%) GRCs developed during the follow-up period; these included thrombotic iliac limb occlusion (n ¼ 1), aneurysmal dilation of CAA (n ¼ 1), aortoenteric fistula (n ¼ 1) after fall down injury, and graft rupture (n ¼ 1). Patient survival and event-free survival rates at 3 years were 77% and 64%, respectively.
Objective: Most endovascular aneurysm repair (EVAR) complications can be treated by endovascular means. However, some patients require open conversion (OC) after EVAR because of complications that are resistant to endovascular treatment. The frequency of OC after EVAR has been variously reported because of different follow-up duration and diagnostic program of the EVAR complications. Surgical morbidity and mortality associated with OC were reported to be significantly higher compared with the standard open surgical repair of abdominal aortic aneurysm. We attempted to search for underlying causes of EVAR failure requiring OC.
Methods: OC was defined as surgical opening of the aneurysmal sac after EVAR regardless of aortic cross-clamping or stent graft removal. To find underlying causes of EVAR failure requiring OC, we retrospectively reviewed history of infection after EVAR, endovascular reintervention after EVAR, pre-and post-EVAR computed tomography images, and angiographic images during the EVAR procedure. Diagnosis and type of endoleak depended on computed tomography, ultrasound, and operative findings. For the diagnosis of endograft infection (EGI), we followed the Management of Aortic Graft Infection Collaboration (MAGIC) criteria (EJVES 2016; 52:758-63) .
Results: Twenty-three OCs (institutional, n ¼ 8) were performed for 22 patients (median age, 75 years; male, 83%) at a mean 26 months (2-130 months) after EVAR during the past 14 years. Our institutional frequency of OC was 1.8% after standard EVAR. Indications for OC were end leak (n
; 1 intraoperative and 3 late ruptures), and continuous sac enlargement without evidence of endoleak (n ¼ 2 [9%]). Endoleaks requiring OC were type IA (n ¼ 5), type IB (n ¼ 1), type IIIA (n ¼ 1), and type IIIB (n ¼ 2). Among nine EGIs, three (33%) patients presented with aortoenteric fistula or erosion. Among the patients with EGI, the infection source was identifiable in four (44%) patients, which included EVAR for patients with infected abdominal aortic aneurysm (n ¼ 2) and coexisting psoas abscess at the time of EVAR (n ¼ 2). Among five late EGIs, three patients showed a remote site infection source, including leg cellulitis, gingival abscess, and bacteremia. Among four aortic ruptures, one patient required OC because of intraoperative aortic rupture during EVAR. As a result of OC, we have experienced one (4%) surgical death and three early postoperative complications, including late midcolic artery rupture in type I neurofibromatosis, left colon ischemia, and acute renal insufficiency.
Conclusions: We think that at least 73% of OCs due to endoleak, 44% of OCs due to EGI, and 25% of aortic ruptures are preventable by proper selection of EVAR candidates and careful endovascular technique. Objective: Infected abdominal aortic aneurysm (AAA) is not uncommon in the Asian population. Open repair has been the "gold standard" treatment for several decades. Endovascular aneurysm repair (EVAR) has been increasingly performed since the last decade. This study aimed to identify which factors affect favorable outcome and persistent infection after EVAR for infected AAA.
Methods: We reviewed a prospective database of all infected AAAs from January 2010 to October 2017. Secondary cases from previous aortic surgery were excluded. The favorable outcome is the patient who can discontinue antibiotics after EVAR. The criteria for stopping antibiotics are the following: no abdominal or back pain or fever; normal white blood cell count, erythrocyte sedimentation rate, and C-reactive protein level; and complete regression of the infected area by computed tomography angiography. In contrast, the criteria for persistent infection are continued antibiotic use and aortic graft-related reintervention. Antibiotic-free survival and overall survival curves were calculated using the Kaplan-Meier method. Log-rank test was performed to compare overall survival curves between favorable and persistent infection groups. Odds ratio was used to assess the magnitude of association between factors and persistent infection by binary logistic regression analysis. Receiver operating characteristic curve was used to classify serum albumin level into two groups.
Results: Sixty-four patients (81% male) with a median age of 72 years (range, 18-94 years) were treated during the study period. Indications for EVAR were 48 (75%) for nonruptured and 16 (25%) for ruptured. The majority of aneurysm morphology was saccular aneurysm (92.2%). The 30-day mortality was 4.7% (3/64); two patients were in the nonruptured group and one patient was in the ruptured group. As for the favorable group, 23 (38.3%) patients could discontinue antibiotics. Estimated median time for discontinuation of antibiotics was 13.4 months (range, 3.2 39.6 months). Neither recurrence of infection nor reintervention occurred in the favorable group. In contrast, 37 (61.7%) patients still had persistent infection. At 3-year follow-up, overall survival rate was 89.3% and 19.2% in the favorable and persistent infection groups, respectively (P < .001). Multiple logistic regression analysis showed only serum albumin level <3 mg/ dL independently associated with persistent infection (adjusted odds ratio, 6.81; 95% confidence interval, 1.56-29.71).
Conclusions: EVAR might be feasible for treatment of infected AAA; the rate of discontinued antibiotics accounts for 38.3% at the median time of 13.4 months. The discontinued antibiotic or favorable group has significantly better outcomes in terms of 3-year survival rate compared with the persistent infection group. Serum albumin level <3 mg/dL might be the factor related to persistent infection.
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